awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36697877-AB80D903-4FE6-4C79-9690-93A9589267DB
Q36697877-AB80D903-4FE6-4C79-9690-93A9589267DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36697877-AB80D903-4FE6-4C79-9690-93A9589267DB
Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report.
P2860
Q36697877-AB80D903-4FE6-4C79-9690-93A9589267DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36697877-AB80D903-4FE6-4C79-9690-93A9589267DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef82040bd5942af32de5c37206f481e519b2adf1
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).